Vaccine effectiveness against severe acute respiratory infections (SARI) COVID-19 hospitalisations estimated from real-world surveillance data, Slovenia, October 2021

We estimated vaccine effectiveness (VE) against severe COVID-19 during October 2021, using Slovenian surveillance data. For people fully vaccinated with any vaccine in age groups 18–49, 50–64, ≥ 65 years, VE was 86% (95% CI: 79–90), 89% (85–91), and 77% (74–81). Among ≥ 65 year-olds fully vaccinated...

Descripción completa

Detalles Bibliográficos
Autores principales: Grgič Vitek, Marta, Klavs, Irena, Učakar, Veronika, Serdt, Mojca, Mrzel, Maja, Vrh, Marjana, Fafangel, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2022
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739341/
https://www.ncbi.nlm.nih.gov/pubmed/34991780
http://dx.doi.org/10.2807/1560-7917.ES.2022.27.1.2101110
_version_ 1784629083243544576
author Grgič Vitek, Marta
Klavs, Irena
Učakar, Veronika
Serdt, Mojca
Mrzel, Maja
Vrh, Marjana
Fafangel, Mario
author_facet Grgič Vitek, Marta
Klavs, Irena
Učakar, Veronika
Serdt, Mojca
Mrzel, Maja
Vrh, Marjana
Fafangel, Mario
author_sort Grgič Vitek, Marta
collection PubMed
description We estimated vaccine effectiveness (VE) against severe COVID-19 during October 2021, using Slovenian surveillance data. For people fully vaccinated with any vaccine in age groups 18–49, 50–64, ≥ 65 years, VE was 86% (95% CI: 79–90), 89% (85–91), and 77% (74–81). Among ≥ 65 year-olds fully vaccinated with mRNA vaccines, VE decreased from 93% (95% CI: 88–96) in those vaccinated ≤ 3 months ago to 43% (95% CI: 30–54) in those vaccinated ≥ 6 months ago, suggesting the need for early boosters.
format Online
Article
Text
id pubmed-8739341
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher European Centre for Disease Prevention and Control (ECDC)
record_format MEDLINE/PubMed
spelling pubmed-87393412022-02-07 Vaccine effectiveness against severe acute respiratory infections (SARI) COVID-19 hospitalisations estimated from real-world surveillance data, Slovenia, October 2021 Grgič Vitek, Marta Klavs, Irena Učakar, Veronika Serdt, Mojca Mrzel, Maja Vrh, Marjana Fafangel, Mario Euro Surveill Rapid Communication We estimated vaccine effectiveness (VE) against severe COVID-19 during October 2021, using Slovenian surveillance data. For people fully vaccinated with any vaccine in age groups 18–49, 50–64, ≥ 65 years, VE was 86% (95% CI: 79–90), 89% (85–91), and 77% (74–81). Among ≥ 65 year-olds fully vaccinated with mRNA vaccines, VE decreased from 93% (95% CI: 88–96) in those vaccinated ≤ 3 months ago to 43% (95% CI: 30–54) in those vaccinated ≥ 6 months ago, suggesting the need for early boosters. European Centre for Disease Prevention and Control (ECDC) 2022-01-06 /pmc/articles/PMC8739341/ /pubmed/34991780 http://dx.doi.org/10.2807/1560-7917.ES.2022.27.1.2101110 Text en This article is copyright of the authors or their affiliated institutions, 2022. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.
spellingShingle Rapid Communication
Grgič Vitek, Marta
Klavs, Irena
Učakar, Veronika
Serdt, Mojca
Mrzel, Maja
Vrh, Marjana
Fafangel, Mario
Vaccine effectiveness against severe acute respiratory infections (SARI) COVID-19 hospitalisations estimated from real-world surveillance data, Slovenia, October 2021
title Vaccine effectiveness against severe acute respiratory infections (SARI) COVID-19 hospitalisations estimated from real-world surveillance data, Slovenia, October 2021
title_full Vaccine effectiveness against severe acute respiratory infections (SARI) COVID-19 hospitalisations estimated from real-world surveillance data, Slovenia, October 2021
title_fullStr Vaccine effectiveness against severe acute respiratory infections (SARI) COVID-19 hospitalisations estimated from real-world surveillance data, Slovenia, October 2021
title_full_unstemmed Vaccine effectiveness against severe acute respiratory infections (SARI) COVID-19 hospitalisations estimated from real-world surveillance data, Slovenia, October 2021
title_short Vaccine effectiveness against severe acute respiratory infections (SARI) COVID-19 hospitalisations estimated from real-world surveillance data, Slovenia, October 2021
title_sort vaccine effectiveness against severe acute respiratory infections (sari) covid-19 hospitalisations estimated from real-world surveillance data, slovenia, october 2021
topic Rapid Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739341/
https://www.ncbi.nlm.nih.gov/pubmed/34991780
http://dx.doi.org/10.2807/1560-7917.ES.2022.27.1.2101110
work_keys_str_mv AT grgicvitekmarta vaccineeffectivenessagainstsevereacuterespiratoryinfectionssaricovid19hospitalisationsestimatedfromrealworldsurveillancedatasloveniaoctober2021
AT klavsirena vaccineeffectivenessagainstsevereacuterespiratoryinfectionssaricovid19hospitalisationsestimatedfromrealworldsurveillancedatasloveniaoctober2021
AT ucakarveronika vaccineeffectivenessagainstsevereacuterespiratoryinfectionssaricovid19hospitalisationsestimatedfromrealworldsurveillancedatasloveniaoctober2021
AT serdtmojca vaccineeffectivenessagainstsevereacuterespiratoryinfectionssaricovid19hospitalisationsestimatedfromrealworldsurveillancedatasloveniaoctober2021
AT mrzelmaja vaccineeffectivenessagainstsevereacuterespiratoryinfectionssaricovid19hospitalisationsestimatedfromrealworldsurveillancedatasloveniaoctober2021
AT vrhmarjana vaccineeffectivenessagainstsevereacuterespiratoryinfectionssaricovid19hospitalisationsestimatedfromrealworldsurveillancedatasloveniaoctober2021
AT fafangelmario vaccineeffectivenessagainstsevereacuterespiratoryinfectionssaricovid19hospitalisationsestimatedfromrealworldsurveillancedatasloveniaoctober2021

Ejemplares similares